Huzhou
Production capacity: 500 tons
Area: 35000 square meters
SENCL
Founded in 2012, SENCL is headquartered in Huzhou
South Taihu Pharmaceutical industrial Park.lt is an international high-tech company driven by synthetic biology technology,with advanced enzyme catalysis, metabolic engineering and bio-fermentation technology,integrating R&D, production and sales.
South Taihu Pharmaceutical industrial Park.lt is an international high-tech company driven by synthetic biology technology,with advanced enzyme catalysis, metabolic engineering and bio-fermentation technology,integrating R&D, production and sales.
The company's main products are a series of fine chemicals for sports nutrition, brain health,anti-aging and longevity, whitening and moisturizing and functional additives. SENCL has become a leading enterprise in many industries such as B-alanine, NAG, and ergothioneine.
Two major research and development centers
Adhering to strict and standardized research and development processes and standards, relving on bia data and artificial
intelligence technology platforms, combining user needs to design, write or modify microbial genomes, constantly
evaluating experiments, developing innovative technology, and enhancing product power.
intelligence technology platforms, combining user needs to design, write or modify microbial genomes, constantly
evaluating experiments, developing innovative technology, and enhancing product power.
Shanghai R&D Center-Center for Synthetic Biology R&D
The total laboratory area is nearly 3,000 square meters
Top-level genetic engineering bacteria constructionplatform, High throughput screening platform,fermentation transformation platform, the world's leadingsupercritical technology.
Huzhou R&D Center -Center for Incubating Research Achievements
The total laboratory area is nearly 2,600 square meters.
It has the leadinglaboratoryinstruments and equipmentin China.
Now there are more than 20 R&D personnel, with a master'sdegree accounting for more than 50%.
Two major research and development centers
From innovative research and development --> pilot transformation --> industrial application of the whole process coverage
R&D Achievements-Terminal Products 40+
Professional R&D personnel 40+
Master's and Doctoral ratio 50%+
Six major R&D technology platforms
Enzyme directed evolution
Metabolic engineering
High throughput screening
Biological fermentation
Biotransformation
Separation and purification
Two major production bases,achieve large-scale mass production
Chuzhou
Production capacity: 15000 tons
Area: 94500 square meters
SENCL pursuits of ultra-pure, efficient,high quality and price ratio of products
Ultrapure Continuously pursuing ultrahigh purity 99.9%
Efficient Continuously pursuing stability and efficiency intelligent manufacturing production bases
High cost-effectiveness Continuously pursuinghigh quality to price ratio At a more reasonable price Enjoy theHighestquality
Focus on biosynthesis technology for 10+ years
2023
Commencement of Chuzhou Factory
2023
Commencement of Huzhou Facto
2022
Completion of Series A Financing
2022
Establishment of Shanghai R&D Center
2018
Launch of New Factory
2017
Establishment of Zhejiang Huarui (SENCL) Biotech Formation of Huzhou R&D Center
2016
High-tech Enterprise Venturing into the Nutritional Health field
2013
Entry into the Pharmaceutical Field
2012
Establishment of SENCL
